Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared on X:
“AACR Enduring Impact Award for Transformative Service to Cancer Science and Medicine to the amazing Rick Pazdur”
More posts featuring Vivek Subbiah on OncoDaily.
